Total Payments
$64,841
2024 Payments
$2,349
Companies
16
Transactions
154
Medicare Patients
12,481
Medicare Billing
$10.4M
Payment Breakdown by Category
Consulting$41,735 (64.4%)
Other$11,500 (17.7%)
Travel$4,657 (7.2%)
Food & Beverage$4,202 (6.5%)
Gifts$2,742 (4.2%)
Education$5.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $41,735 | 17 | 64.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,500 | 10 | 17.7% |
| Travel and Lodging | $4,657 | 24 | 7.2% |
| Food and Beverage | $4,202 | 100 | 6.5% |
| Gift | $2,742 | 2 | 4.2% |
| Education | $5.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $27,877 | 55 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $27,080 | 43 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $2,993 | 1 | $0 (2017) |
| Alcon Laboratories Inc | $2,853 | 3 | $0 (2018) |
| Coherus Biosciences Inc. | $1,375 | 1 | $0 (2021) |
| Genentech USA, Inc. | $1,309 | 24 | $0 (2024) |
| Alimera Sciences, Inc. | $767.06 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $181.45 | 7 | $0 (2024) |
| Biogen, Inc. | $94.99 | 4 | $0 (2023) |
| ASD Specialty Healthcare, LLC | $89.69 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,349 | 24 | Regeneron Healthcare Solutions, Inc. ($2,069) |
| 2023 | $1,290 | 18 | Alimera Sciences, Inc. ($736.89) |
| 2022 | $1,893 | 12 | Regeneron Healthcare Solutions, Inc. ($1,087) |
| 2021 | $16,369 | 14 | Regeneron Healthcare Solutions, Inc. ($14,119) |
| 2020 | $6,947 | 14 | Allergan, Inc. ($6,859) |
| 2019 | $4,534 | 9 | Allergan Inc. ($4,447) |
| 2018 | $6,252 | 14 | Regeneron Healthcare Solutions, Inc. ($4,194) |
| 2017 | $25,208 | 49 | Allergan Inc. ($14,950) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $724.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: Ophthalmology | ||||||
| 10/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $62.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $180.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: Ophthalmology | ||||||
| 09/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: Ophthalmology | ||||||
| 08/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/12/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: Ophthalmology | ||||||
| 05/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $82.23 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/03/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Ophthalmology | ||||||
| 04/03/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: EYE CARE | ||||||
| 03/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/22/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Consulting Fee | Cash or cash equivalent | $739.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $104.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,896 | 21,309 | $4.8M | $2.4M |
| 2022 | 17 | 3,120 | 13,458 | $4.9M | $2.5M |
| 2021 | 16 | 3,245 | 13,137 | $5.0M | $2.8M |
| 2020 | 14 | 3,220 | 12,756 | $4.6M | $2.6M |
Total Patients
12,481
Total Services
60,660
Medicare Billing
$10.4M
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 174 | 1,694 | $1.8M | $1.2M | 63.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 101 | 2,565 | $1.2M | $460,989 | 38.4% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 34 | 10,680 | $480,600 | $311,102 | 64.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 507 | 1,565 | $344,300 | $149,725 | 43.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 330 | 1,418 | $438,000 | $142,553 | 32.5% |
| 92134 | Imaging of retina | Office | 2023 | 752 | 2,091 | $208,800 | $62,901 | 30.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 389 | 505 | $98,475 | $44,697 | 45.4% |
| J3590 | Unclassified biologics | Office | 2023 | 48 | 175 | $52,000 | $19,775 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $25,200 | $11,341 | 45.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 77 | 78 | $21,840 | $8,420 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 119 | $18,445 | $8,118 | 44.0% |
| 92250 | Photography of the retina | Office | 2023 | 126 | 144 | $18,000 | $3,931 | 21.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $5,510 | $2,244 | 40.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 19 | 19 | $4,370 | $1,855 | 42.5% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 74 | 82 | $4,920 | $1,550 | 31.5% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 15 | 17 | $1,955 | $616.15 | 31.5% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 37 | 38 | $1,710 | $419.64 | 24.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 190 | 1,720 | $1.9M | $1.2M | 65.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 153 | 3,492 | $1.6M | $776,422 | 47.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 371 | 1,541 | $454,000 | $149,158 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 481 | 1,537 | $338,090 | $147,094 | 43.5% |
| 92134 | Imaging of retina | Office | 2022 | 704 | 2,081 | $208,050 | $63,393 | 30.5% |
| J3590 | Unclassified biologics | Office | 2022 | 62 | 203 | $110,250 | $53,829 | 48.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 16 | 1,560 | $69,699 | $46,553 | 66.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 406 | 500 | $97,500 | $45,958 | 47.1% |
About Dr. Alan Ruby, MD
Dr. Alan Ruby, MD is a Ophthalmology healthcare provider based in Royal Oak, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801828025.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Ruby, MD has received a total of $64,841 in payments from pharmaceutical and medical device companies, with $2,349 received in 2024. These payments were reported across 154 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($41,735).
As a Medicare-enrolled provider, Ruby has provided services to 12,481 Medicare beneficiaries, totaling 60,660 services with total Medicare billing of $10.4M. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Royal Oak, MI
- Active Since 07/07/2006
- Last Updated 01/04/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1801828025
Products in Payments
- OZURDEX (Drug) $27,960
- EYLEA (Biological) $16,143
- EYLEA AFLIBERCEPT INJECTION (Biological) $12,540
- NGENUITY (Device) $2,742
- EYLEA HD (Biological) $1,389
- Lucentis (Biological) $814.53
- ILUVIEN (Drug) $767.06
- Vabysmo (Drug) $368.08
- Izervay (Drug) $149.29
- Constellation (Device) $110.43
- BEOVU (Drug) $37.97
- VABYSMO (Drug) $35.64
- Syfovre (Drug) $33.62
- XIPERE (Drug) $22.73
- ALREX (Drug) $17.14
- LOTEMAX GEL (Drug) $5.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Royal Oak
Dr. Jeremy Wolfe, Md, MD
Ophthalmology — Payments: $851,975
Ophthalmology $851,975
Dr. Tarek Hassan, Md, MD
Ophthalmology — Payments: $422,858
Ophthalmology $422,858
Dr. Kimberly Drenser, Md, MD
Ophthalmology — Payments: $70,185
Ophthalmology $70,185
Dr. Antonio Capone, Md, MD
Ophthalmology — Payments: $66,718
Ophthalmology $66,718
Sandeep Randhawa, Md, MD
Ophthalmology — Payments: $58,625
Ophthalmology $58,625
Dr. George Williams, Md, MD
Ophthalmology — Payments: $46,707
Ophthalmology $46,707